Synthesis, characterization, anti-proliferative, and apoptotic activity of a novel quinazoline-containing 1,2,3-triazole toward three human cancer cells
Abstract A novel quinazoline-containing 1,2,3-triazole (4-TCPA) was synthesized to target VEGFR2 signaling for cancer treatment. Although current VEGFR2 inhibitors exhibit strong anticancer activity, their clinical use is limited due to severe side effects. Structural analysis of effective VEGFR2 in...
Saved in:
| Main Authors: | Mohammad Javad Dehghan-Nayeri, Fariba Peytam, Alireza Foroumadi, Majid Mahdavi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05270-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity
by: Adel A.-H. Abdel-Rahman, et al.
Published: (2024-10-01) -
Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors
by: Alexandru Șandor, et al.
Published: (2025-02-01) -
A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
by: Fatemeh Yousefbeyk, et al.
Published: (2025-01-01) -
2D-QSAR driven design, molecular docking, molecular dynamics simulation and MM/GBSA studies on quinazoline derivatives for development of VEGFR-2 inhibitors
by: Mayank Kashyap, et al.
Published: (2025-05-01) -
A Systematic Review of Synthetic and Anticancer and Antimicrobial Activity of Quinazoline/Quinazolin‐4‐one Analogues
by: Neha Manhas, et al.
Published: (2025-07-01)